RMDA Opportunities Exposure to "RMDA" stock
On testing the resistance at the 2.20 level, it rose to approximately 5%, and there are opportunities for growth during approximately the week’s session on the 2.5 test.
0.154EGP
223.50 MEGP
1.92 BEGP
1.00 B
About TENTH OF RAMADAN PHARMACEUTICAL INDUSTRIES&DIAGNOSTIC-RAMEDA
Sector
CEO
Amr Morsy
Headquarters
6th of October City
Website
Founded
1986
ISIN
EGS381B1C015
FIGI
BBG006L8GPB0
Tenth of Ramadan Company for Pharmaceuticals Industries & Diagnostic Reagents S.A.E. engages in the manufacture and marketing of pharmaceutical products for human and veterinary use. It operates through Production and Selling of Pharmaceutical Products; and Manufacturing for Others segments. The firm product categories include anti-infective, anti-diabetic, respiratory, ophthalmology, gastro-intestinal tract, cardio-vascular, central nervous system, vitamins, and analgesics. The company was founded on January 15, 1986 and is headquartered in 6th of October City, Egypt.
RMDA faces strong resistance at 2.5The chart shows strong resistance for Monday at the 2.5 level that cannot be broken, and there is a lack of desire from the market maker to break this level. Support is expected at the 2.29 level. The expected scenario is that the stock will move sideways for the rest of the trading week until a "fl
trading in the KUMO trading in the green kumo, chikou is facing down, and red kumo formation means irrational decison.
hold your horses .. other opportunities exists in the healthcare sector
Good setup on RMDA It has a probability of a good uptrend imo.
the trade requires good risk management and patience.
NEXT MARKET MOVE UP TO 2023NEXT MARKET MOVE UP TO 2023
At the bold black line, a major area,
At the orange line, a sub area
WE CAN UPDATE AFTER BROKEN
Rameda stock analysisThis is a personal expectation of the future of the stock. You are the first and last responsible for your opinion of entering or exiting
RMDA EGX EGYPT - shady alsadany RMDA EGX EGYPT - shady alsadany
Company Name : Tenth Of Ramadan Pharmaceutical Industries
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of RMDA is 2.250 EGP — it has decreased by 0.88% in the past 24 hours. Watch TENTH OF RAMADAN PHARMACEUTICAL INDUSTRIES&DIAGNOSTIC-RAMEDA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on EGX exchange TENTH OF RAMADAN PHARMACEUTICAL INDUSTRIES&DIAGNOSTIC-RAMEDA stocks are traded under the ticker RMDA.
RMDA stock has fallen by 0.88% compared to the previous week, the month change is a 9.22% rise, over the last year TENTH OF RAMADAN PHARMACEUTICAL INDUSTRIES&DIAGNOSTIC-RAMEDA has showed a 47.03% increase.
We've gathered analysts' opinions on TENTH OF RAMADAN PHARMACEUTICAL INDUSTRIES&DIAGNOSTIC-RAMEDA future price: according to them, RMDA price has a max estimate of 3.97 EGP and a min estimate of 3.42 EGP. Watch RMDA chart and read a more detailed TENTH OF RAMADAN PHARMACEUTICAL INDUSTRIES&DIAGNOSTIC-RAMEDA stock forecast: see what analysts think of TENTH OF RAMADAN PHARMACEUTICAL INDUSTRIES&DIAGNOSTIC-RAMEDA and suggest that you do with its stocks.
RMDA reached its all-time high on Feb 26, 2024 with the price of 3.400 EGP, and its all-time low was 0.126 EGP and was reached on Nov 27, 2019. View more price dynamics on RMDA chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
RMDA stock is 4.55% volatile and has beta coefficient of 0.53. Track TENTH OF RAMADAN PHARMACEUTICAL INDUSTRIES&DIAGNOSTIC-RAMEDA stock price on the chart and check out the list of the most volatile stocks — is TENTH OF RAMADAN PHARMACEUTICAL INDUSTRIES&DIAGNOSTIC-RAMEDA there?
Today TENTH OF RAMADAN PHARMACEUTICAL INDUSTRIES&DIAGNOSTIC-RAMEDA has the market capitalization of 3.45 B, it has increased by 4.19% over the last week.
Yes, you can track TENTH OF RAMADAN PHARMACEUTICAL INDUSTRIES&DIAGNOSTIC-RAMEDA financials in yearly and quarterly reports right on TradingView.
RMDA net income for the last quarter is 57.01 M EGP, while the quarter before that showed 47.53 M EGP of net income which accounts for 19.93% change. Track more TENTH OF RAMADAN PHARMACEUTICAL INDUSTRIES&DIAGNOSTIC-RAMEDA financial stats to get the full picture.
TENTH OF RAMADAN PHARMACEUTICAL INDUSTRIES&DIAGNOSTIC-RAMEDA dividend yield was 3.93% in 2023, and payout ratio reached 44.70%. The year before the numbers were 0% and 0% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. TENTH OF RAMADAN PHARMACEUTICAL INDUSTRIES&DIAGNOSTIC-RAMEDA EBITDA is 511.32 M EGP, and current EBITDA margin is 26.02%. See more stats in TENTH OF RAMADAN PHARMACEUTICAL INDUSTRIES&DIAGNOSTIC-RAMEDA financial statements.
Like other stocks, RMDA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TENTH OF RAMADAN PHARMACEUTICAL INDUSTRIES&DIAGNOSTIC-RAMEDA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So TENTH OF RAMADAN PHARMACEUTICAL INDUSTRIES&DIAGNOSTIC-RAMEDA technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating TENTH OF RAMADAN PHARMACEUTICAL INDUSTRIES&DIAGNOSTIC-RAMEDA stock shows the buy signal. See more of TENTH OF RAMADAN PHARMACEUTICAL INDUSTRIES&DIAGNOSTIC-RAMEDA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.